This public procurement contract involves the ongoing supply of medicinal products containing the active ingredient Avelumab, specifically in a concentration of 20 MG/ML. The products will be provided in 10 ML vials as an infusion solution. Deliveries will be made based on individual orders accordin
Tender closed on 23 Jan 2026. Awaiting award.
This public procurement contract involves the ongoing supply of medicinal products containing the active ingredient Palbociclib in the form of coated tablets with strengths of 125 mg, 100 mg, and 75 mg, packaged in units of 21. The contract will last for two years, starting from the effective date,
This contract involves the ongoing supply of plastic bags for the Liberec Regional Hospital. Suppliers are invited to provide plastic bags and sacks, which are essential for the hospital's operations. The total value of the contract is approximately 459,882 CZK. This opportunity is part of a dynamic
Develop medical countermeasures for CBRN threats with up to £4 million funding over 30 months, from prototype through Phase 2a clinical studies.
A three-year funded fellowship helping healthcare professionals with PhDs return to clinical research after extended career breaks.
Opportunity to provide a digital mental health platform delivering NICE-recommended therapeutic interventions and resources for children, young people, and families in South Staffordshire.
Opportunity for Primary Care Networks to deliver integrated COPD identification and specialist support services using digital risk stratification across Hull and East Yorkshire communities.
